Submit your Bosentan claim details for a free, no obligation case review
Get Started:
What is pulmonary hypertension?
Pulmonary hypertension is present when pulmonary arterial pressure is greater
than 25 mm Hg at rest or 30 mm Hg during exercise. Associated to the use
of diet drugs Fen Phen, Redux, and Pondimin, pulmonary hypertension has
no cure. The most common symptoms of pulmonary hypertension are shortness
of breath with exertion and general fatigue.
What is Bosentan?
Bosentan is the first oral medication treatment for pulmonary arterial hypertension
(PAH) intended to improve the exercise ability of patients due to the abnormally
high blood pressure in the arteries located between the heart and lungs.
What is Remodulin?
Remodulin is a synthetic, stable form of prostacyclin to treat PAH. This
pulmonary hypertension treatment is a new treatment approved under accelerated
approval regulations for advanced pulmonary hypertension. Manufactured by
United Therapeutics, Remodulin was FDA approved on May 22, 2002 based on
the largest double blind placebo-controlled study ever conducted in PAH.
What is Flolan?
Flolan is known as an epoprostenol, a manufactured copy of the natural occurring
chemical prostaglandin. Administering Flolan is also very complex, and because
of the lack of qualified clinicians, Flolan patients must use special health
care services to learn about administering Flolan treatment. A surgically
implanted catheter is used with a battery-operated pump. The Flolan is administered
intravenously directly into the bloodstream through the catheter. The Flolan
is slowly and continuously pumped into the bloodstream because it only lasts
3-5 minutes, and the PPH patients must wear the pump attached to a waist
belt on in a shoulder pack.
What is Tracleer?
Tracleer is the brand name of Bosentan manufactured by Actelion Pharmaceutic
Pulmonary arterial hypertension (PAH) is a rare disorder that strikes mostly women in the prime of their lives. The disorder elevates the blood pressure in the artery between the heart and lungs and usually proves to be fatally within three years of th...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.